Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Blocking Tumor Necrosis Factor α enhances CD8 T cell-dependent immunity in experimental melanoma.
TNF-R1-dependent TNF signaling impairs tumor-infiltrating CD8+ T cell accumulation.
»
05/16/15
The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
Selected VEGFR2, COX-2 and MMP-2 polymorphisms may be potential prognostic markers in unresectable NSCLC.
»
01/12/15
Vitamin E intake from natural sources and head and neck cancer risk: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
Intake of vitamin E was inversely related to oral/pharyngeal cancer.
»
12/19/14
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.
Elevation of AEA and alteration of ceramides (C16, C24, C18, C20) may qualify as potential endogenous biomarkers.
»
03/09/15
Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
Adverse prognostic significance of LDH and IL-8 was found to be enhanced in obese patients.
»
11/26/14
Expression of WNT genes in cervical cancer-derived cells: Implication of WNT7A in cell proliferation and migration.
Reduced WNT7A levels reported in CC-derived cells.
»
11/04/14
miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
SMAD2 overexpression partially reversed the cellular phenotypes induced by miR-212/132 overexpression.
»
02/14/15
miR-520h is crucial for DAPK2 regulation and breast cancer progression.
Essential role of miR-520h-suppressed Death-associated protein kinase 2 (DAPK2) expression confirmed.
»
08/22/14
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells.
Patients with BRCA1 allelic loss may also benefit from PARP inhibitor therapy.
»
03/04/15
Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
IL-8 siRNA attenuated the phosphorylation of PI3K and Akt and inhibited NF-κB activity.
»
06/28/14
< Prev
Next >